Bryce Point Capital LLC purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 64,043 shares of the medical instruments supplier’s stock, valued at approximately $1,216,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 564 shares during the period. MML Investors Services LLC boosted its stake in DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock worth $803,000 after purchasing an additional 620 shares during the period. Blue Trust Inc. grew its position in DENTSPLY SIRONA by 10.9% during the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after purchasing an additional 707 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares in the last quarter. Finally, Riverview Trust Co acquired a new stake in DENTSPLY SIRONA during the 4th quarter valued at $26,000. Institutional investors and hedge funds own 95.70% of the company’s stock.
DENTSPLY SIRONA Trading Up 1.5 %
Shares of NASDAQ:XRAY opened at $14.87 on Thursday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $2.96 billion, a PE ratio of -7.18, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 1 year low of $14.50 and a 1 year high of $33.02. The firm has a fifty day moving average price of $17.37 and a 200 day moving average price of $19.93.
DENTSPLY SIRONA Dividend Announcement
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on XRAY shares. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Mizuho lowered their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research note on Thursday, March 13th. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $23.33.
View Our Latest Analysis on DENTSPLY SIRONA
Insider Activity at DENTSPLY SIRONA
In related news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- Dividend Payout Ratio Calculator
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- 3 Monster Growth Stocks to Buy Now
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Where Do I Find 52-Week Highs and Lows?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.